Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

James Suen

Concepts (317)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arteriovenous Malformations
9
2018
66
1.620
Why?
Head and Neck Neoplasms
14
2012
273
1.360
Why?
Carcinoma, Squamous Cell
12
2011
318
0.920
Why?
Neck
7
2018
100
0.740
Why?
Vascular Malformations
3
2010
98
0.690
Why?
Head
5
2018
73
0.650
Why?
Patients
1
2018
49
0.600
Why?
Terminal Care
1
2018
46
0.600
Why?
Hemangioma
3
2018
83
0.570
Why?
Laryngectomy
3
2013
28
0.560
Why?
Attitude to Health
1
2018
191
0.560
Why?
Flow Cytometry
7
2024
476
0.560
Why?
Laryngeal Neoplasms
2
2007
42
0.530
Why?
Carcinoma, Merkel Cell
4
2016
41
0.480
Why?
Quality of Life
3
2012
839
0.480
Why?
Laser Therapy
3
2011
84
0.470
Why?
Laryngeal Diseases
1
2013
12
0.430
Why?
Herpes Simplex
1
2013
21
0.430
Why?
Parotid Diseases
1
2012
3
0.430
Why?
Neuromuscular Agents
1
2012
7
0.430
Why?
Nuclear Proteins
6
2015
243
0.420
Why?
Botulinum Toxins, Type A
1
2012
13
0.420
Why?
Leukoplakia, Oral
1
2011
6
0.400
Why?
Aminolevulinic Acid
1
2011
8
0.400
Why?
Lasers, Dye
1
2011
9
0.400
Why?
Eating
1
2012
161
0.400
Why?
Photosensitizing Agents
1
2011
21
0.390
Why?
Photochemotherapy
1
2011
34
0.390
Why?
Survivors
1
2012
125
0.380
Why?
Female
30
2024
26635
0.380
Why?
Humans
49
2024
50208
0.370
Why?
Middle Aged
21
2024
12206
0.370
Why?
Male
30
2024
25399
0.360
Why?
Photoacoustic Techniques
2
2024
72
0.360
Why?
Cheek
1
2010
9
0.350
Why?
Lip
1
2010
11
0.350
Why?
Neoplastic Cells, Circulating
4
2019
74
0.350
Why?
Facial Neoplasms
1
2010
22
0.350
Why?
Pain
1
2012
381
0.340
Why?
Adult
21
2024
13324
0.340
Why?
Aged
16
2018
9405
0.340
Why?
Receptors, Progesterone
1
2009
64
0.340
Why?
Postoperative Complications
3
2012
996
0.330
Why?
Lymphatic Vessels
1
2009
48
0.330
Why?
Skin Neoplasms
4
2016
492
0.320
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2004
990
0.310
Why?
Neoplasms
1
2018
1249
0.310
Why?
Recurrent Laryngeal Nerve
1
2007
13
0.300
Why?
Laryngeal Nerves
1
2007
16
0.300
Why?
Surgical Flaps
1
2009
120
0.300
Why?
Factor VII
1
2007
3
0.290
Why?
Erythrocytes
2
2024
83
0.290
Why?
Melanoma
2
2022
290
0.290
Why?
Intracranial Arteriovenous Malformations
1
2007
29
0.280
Why?
Dilatation
2
2017
26
0.280
Why?
Malaria
2
2024
37
0.260
Why?
Adolescent
11
2024
6390
0.250
Why?
Gene Silencing
4
2009
118
0.240
Why?
Disease Models, Animal
3
2016
1458
0.240
Why?
Cell Proliferation
4
2016
1013
0.220
Why?
Retrospective Studies
10
2015
6134
0.220
Why?
Melanoma, Experimental
2
2016
45
0.210
Why?
Immunohistochemistry
8
2014
978
0.210
Why?
Treatment Outcome
7
2018
5155
0.210
Why?
Muscarinic Agonists
1
2002
10
0.210
Why?
Xerostomia
1
2002
3
0.210
Why?
Sjogren's Syndrome
1
2002
9
0.210
Why?
Promoter Regions, Genetic
7
2015
475
0.210
Why?
Endoscopy
2
2015
124
0.200
Why?
Thiophenes
1
2002
36
0.200
Why?
Plasmodium yoelii
1
2022
14
0.200
Why?
Nitric Oxide Synthase Type III
2
2013
78
0.200
Why?
Quinuclidines
1
2002
40
0.200
Why?
Veins
3
2010
71
0.190
Why?
Transcription Factors
2
2015
564
0.190
Why?
Embolization, Therapeutic
3
2011
86
0.190
Why?
Azepines
3
2016
18
0.190
Why?
Triazoles
3
2016
109
0.180
Why?
Child
10
2012
6851
0.170
Why?
Child, Preschool
8
2012
3883
0.170
Why?
Neoplasm Invasiveness
3
2010
266
0.170
Why?
Mast Cells
1
2018
52
0.160
Why?
Mice
10
2022
5759
0.150
Why?
Ki-67 Antigen
3
2013
57
0.150
Why?
Combined Modality Therapy
4
2018
636
0.150
Why?
Cricoid Cartilage
1
2017
11
0.150
Why?
Estradiol
1
2018
225
0.140
Why?
Trachea
1
2017
52
0.140
Why?
Mice, Nude
5
2016
254
0.140
Why?
Follow-Up Studies
3
2011
2190
0.140
Why?
Infant
7
2018
3563
0.140
Why?
Biopsy
3
2015
590
0.140
Why?
Lasers, Semiconductor
2
2022
10
0.140
Why?
Embolism
1
2016
20
0.140
Why?
Neoplasm Staging
2
2010
738
0.130
Why?
Benzoxazoles
1
2016
11
0.130
Why?
Matrix Metalloproteinase 2
1
2016
57
0.130
Why?
Qualitative Research
1
2018
336
0.130
Why?
Matrix Metalloproteinase 9
1
2016
89
0.130
Why?
Tracheotomy
1
2015
13
0.130
Why?
TOR Serine-Threonine Kinases
1
2016
77
0.130
Why?
Tracheal Stenosis
1
2015
12
0.130
Why?
Laryngostenosis
1
2015
11
0.130
Why?
Aged, 80 and over
6
2015
3154
0.130
Why?
Proto-Oncogene Proteins c-myb
1
2015
8
0.130
Why?
Larynx
2
2017
30
0.120
Why?
Pyrimidines
1
2016
193
0.120
Why?
Proto-Oncogene Proteins c-myc
1
2014
50
0.120
Why?
Disease Progression
3
2014
831
0.120
Why?
Fluorouracil
2
2004
54
0.120
Why?
Gene Expression Regulation, Neoplastic
3
2015
828
0.120
Why?
Carcinoma
2
2012
139
0.120
Why?
DNA Methylation
5
2009
550
0.110
Why?
Plasmodium falciparum
2
2024
18
0.110
Why?
Breast Neoplasms
2
2015
1179
0.110
Why?
Apoptosis
2
2016
1112
0.110
Why?
Animals
10
2022
13246
0.110
Why?
Mastication
1
2012
5
0.110
Why?
Trismus
1
2012
3
0.110
Why?
DNA, Neoplasm
2
2011
147
0.100
Why?
Radiotherapy, Adjuvant
1
2012
61
0.100
Why?
Adaptor Proteins, Signal Transducing
3
2009
198
0.100
Why?
Cisplatin
2
2004
278
0.100
Why?
Recurrence
2
2011
662
0.100
Why?
Receptors, Cell Surface
1
2013
125
0.100
Why?
Lymphangioma, Cystic
1
2011
10
0.100
Why?
Chemoradiotherapy
1
2012
40
0.100
Why?
Cross-Sectional Studies
3
2024
1554
0.100
Why?
Endothelium, Lymphatic
1
2011
12
0.100
Why?
Syndrome
1
2012
238
0.100
Why?
Administration, Topical
1
2011
56
0.100
Why?
Epigenesis, Genetic
1
2015
378
0.100
Why?
Antigens, CD
1
2013
221
0.100
Why?
Propranolol
1
2012
78
0.100
Why?
Lymphatic Abnormalities
1
2011
22
0.100
Why?
Immunoenzyme Techniques
4
2016
145
0.100
Why?
Enteral Nutrition
1
2012
147
0.100
Why?
Microtubule-Associated Proteins
1
2011
67
0.100
Why?
Deglutition Disorders
1
2012
77
0.100
Why?
Homeodomain Proteins
1
2011
80
0.100
Why?
Brain Neoplasms
1
2014
288
0.090
Why?
Tumor Suppressor Proteins
1
2011
128
0.090
Why?
Diagnosis, Differential
2
2011
1043
0.090
Why?
Risk Assessment
1
2015
1262
0.090
Why?
Epigenomics
1
2011
68
0.090
Why?
Weight Gain
1
2012
239
0.090
Why?
Xenograft Model Antitumor Assays
3
2016
212
0.090
Why?
Lip Neoplasms
1
2010
3
0.090
Why?
Neoplasm Proteins
2
2003
324
0.090
Why?
Diagnostic Imaging
1
2011
177
0.090
Why?
Neoplasm Recurrence, Local
2
2019
613
0.090
Why?
Neoplastic Stem Cells
1
2011
103
0.090
Why?
Neoadjuvant Therapy
1
2011
117
0.090
Why?
Hospitals, Teaching
1
2010
53
0.090
Why?
Survival Rate
3
2011
901
0.090
Why?
Lasers, Solid-State
1
2010
32
0.090
Why?
Microsatellite Instability
1
2009
17
0.090
Why?
Melanins
1
2009
27
0.090
Why?
Medical Records
1
2010
83
0.090
Why?
Young Adult
3
2024
3981
0.090
Why?
Mouth
1
2010
33
0.090
Why?
Vascular Surgical Procedures
1
2011
164
0.090
Why?
Multiple Endocrine Neoplasia Type 2a
1
2009
5
0.090
Why?
Carcinoma, Medullary
1
2009
12
0.080
Why?
Pilot Projects
1
2011
697
0.080
Why?
Proto-Oncogene Proteins c-ret
1
2009
33
0.080
Why?
Receptors, Estrogen
1
2009
131
0.080
Why?
Receptors, Vascular Endothelial Growth Factor
1
2008
22
0.080
Why?
Immunotherapy
1
2011
240
0.080
Why?
Muscle, Smooth, Vascular
1
2009
129
0.080
Why?
Port-Wine Stain
1
2008
14
0.080
Why?
Blotting, Western
3
2016
601
0.080
Why?
Dose-Response Relationship, Drug
1
2011
1378
0.080
Why?
Early Detection of Cancer
2
2022
167
0.080
Why?
Thyroid Neoplasms
1
2009
111
0.070
Why?
Cytokines
1
2011
613
0.070
Why?
Vascular Endothelial Growth Factor A
1
2008
202
0.070
Why?
Tumor Cells, Cultured
3
2016
468
0.070
Why?
Practice Guidelines as Topic
1
2010
449
0.070
Why?
Factor VIIa
1
2007
9
0.070
Why?
Jaw Diseases
1
2007
6
0.070
Why?
Infant, Newborn
2
2011
2766
0.070
Why?
Practice Management, Medical
1
2006
10
0.070
Why?
Osteonecrosis
1
2007
34
0.070
Why?
Postoperative Hemorrhage
1
2007
51
0.070
Why?
Tongue
1
2007
39
0.070
Why?
Bone Density Conservation Agents
1
2007
74
0.070
Why?
Otolaryngology
1
2006
56
0.070
Why?
Diphosphonates
1
2007
90
0.070
Why?
Cell Line, Tumor
3
2015
1416
0.070
Why?
Recombinant Proteins
1
2007
487
0.060
Why?
Prospective Studies
1
2011
2379
0.060
Why?
Skin
1
2008
415
0.060
Why?
Mice, Inbred NOD
2
2016
96
0.060
Why?
Cameroon
1
2024
4
0.060
Why?
Mice, SCID
2
2016
176
0.060
Why?
Hemeproteins
1
2024
8
0.060
Why?
Parasitemia
1
2024
8
0.060
Why?
Malaria, Falciparum
1
2024
13
0.060
Why?
O(6)-Methylguanine-DNA Methyltransferase
1
2004
9
0.060
Why?
Neoplasm Metastasis
2
2015
236
0.060
Why?
DNA Repair Enzymes
1
2004
44
0.060
Why?
Ataxia Telangiectasia
1
2004
6
0.060
Why?
ROC Curve
1
2024
232
0.060
Why?
Statistics, Nonparametric
1
2004
193
0.060
Why?
Polymerase Chain Reaction
4
2009
454
0.060
Why?
Genes, p16
1
2003
9
0.060
Why?
Lymph Node Excision
1
2004
137
0.060
Why?
Radiotherapy
1
2004
127
0.060
Why?
Proteoglycans
1
2003
80
0.050
Why?
Magnetic Resonance Angiography
2
2018
76
0.050
Why?
Antigens, Nuclear
2
2013
24
0.050
Why?
Magnetic Resonance Imaging
2
2007
1541
0.050
Why?
Transplantation, Heterologous
2
2013
75
0.050
Why?
Longitudinal Studies
1
2024
695
0.050
Why?
Sensitivity and Specificity
1
2024
863
0.050
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2016
595
0.050
Why?
Membrane Glycoproteins
1
2003
246
0.050
Why?
Double-Blind Method
1
2002
688
0.050
Why?
Survival Analysis
3
2009
666
0.040
Why?
Tryptases
1
2018
4
0.040
Why?
Estrogen Receptor beta
1
2018
54
0.040
Why?
Arkansas
1
2004
1985
0.040
Why?
Estrogen Receptor alpha
1
2018
89
0.040
Why?
Protein Transport
1
2018
183
0.040
Why?
Ultrasonography, Doppler
1
2018
42
0.040
Why?
Biopsy, Fine-Needle
2
2009
103
0.040
Why?
Cadaver
1
2017
97
0.040
Why?
Pressure
1
2017
106
0.040
Why?
Risk Factors
3
2015
3629
0.030
Why?
Serum
1
2016
32
0.030
Why?
Molecular Imaging
1
2016
53
0.030
Why?
Drug Synergism
1
2016
151
0.030
Why?
Jumonji Domain-Containing Histone Demethylases
1
2015
17
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2016
181
0.030
Why?
Acetylation
1
2015
97
0.030
Why?
Enhancer Elements, Genetic
1
2015
61
0.030
Why?
Keratin-20
1
2014
7
0.030
Why?
Mammography
1
2015
94
0.030
Why?
G1 Phase Cell Cycle Checkpoints
1
2014
18
0.030
Why?
Drug Therapy, Combination
1
2016
381
0.030
Why?
Prognosis
3
2004
1954
0.030
Why?
Chromatin
1
2015
152
0.030
Why?
Cell Cycle Proteins
1
2015
166
0.030
Why?
HEK293 Cells
1
2014
224
0.030
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2013
32
0.030
Why?
Gene Expression Regulation
1
2018
979
0.030
Why?
Comorbidity
1
2015
613
0.030
Why?
Protein Binding
1
2015
665
0.030
Why?
Down-Regulation
1
2014
349
0.030
Why?
Actins
1
2013
119
0.030
Why?
RNA, Messenger
1
2016
1108
0.030
Why?
Base Sequence
2
2004
644
0.030
Why?
Lymphocele
1
2011
7
0.030
Why?
Tissue Survival
1
2011
10
0.030
Why?
Predictive Value of Tests
1
2014
905
0.020
Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
47
0.020
Why?
Tissue Culture Techniques
1
2011
40
0.020
Why?
Cell Line
1
2014
1021
0.020
Why?
Neoplasms, Squamous Cell
1
2011
7
0.020
Why?
Gluconates
1
2011
1
0.020
Why?
Gene Expression Profiling
1
2016
1037
0.020
Why?
Graft Survival
1
2011
150
0.020
Why?
Indomethacin
1
2011
38
0.020
Why?
Injections, Subcutaneous
1
2011
54
0.020
Why?
Interleukin-2
1
2011
72
0.020
Why?
Carrier Proteins
2
2003
306
0.020
Why?
Time Factors
2
2007
2922
0.020
Why?
Interleukin-1beta
1
2011
75
0.020
Why?
Cyclophosphamide
1
2011
166
0.020
Why?
Interferon-gamma
1
2011
176
0.020
Why?
Drug Administration Schedule
1
2011
377
0.020
Why?
Glottis
1
2010
32
0.020
Why?
Disease-Free Survival
1
2011
454
0.020
Why?
Endothelial Cells
1
2011
270
0.020
Why?
Sclerotherapy
1
2010
46
0.020
Why?
Calcitonin
1
2009
30
0.020
Why?
Tumor Necrosis Factor-alpha
1
2011
388
0.020
Why?
Thyroidectomy
1
2009
60
0.020
Why?
Paraffin Embedding
1
2008
53
0.020
Why?
Mice, Transgenic
1
2009
550
0.020
Why?
Signal Transduction
1
2014
1622
0.020
Why?
Curettage
1
2007
13
0.020
Why?
Dental Care
1
2007
11
0.020
Why?
Mouth Floor
1
2007
5
0.020
Why?
Polyvinyl Alcohol
1
2007
9
0.020
Why?
Hyperbaric Oxygenation
1
2007
13
0.020
Why?
Current Procedural Terminology
1
2006
7
0.020
Why?
Collateral Circulation
1
2007
39
0.020
Why?
Pharyngeal Diseases
1
2007
14
0.020
Why?
Insurance, Health, Reimbursement
1
2006
24
0.020
Why?
Cutaneous Fistula
1
2007
15
0.020
Why?
Neck Dissection
1
2007
31
0.020
Why?
Office Visits
1
2006
40
0.020
Why?
Angiography
1
2007
130
0.020
Why?
Fistula
1
2007
26
0.020
Why?
Adrenal Cortex Hormones
1
2007
94
0.020
Why?
Salvage Therapy
1
2007
139
0.020
Why?
Genetic Predisposition to Disease
1
2009
509
0.020
Why?
Imidazoles
1
2007
128
0.020
Why?
Preoperative Care
1
2007
166
0.020
Why?
Ultrasonography
1
2006
437
0.020
Why?
United States
1
2015
4874
0.020
Why?
Guanine
1
2004
40
0.010
Why?
DNA Adducts
1
2004
77
0.010
Why?
Syndecans
1
2003
34
0.010
Why?
Methylation
1
2004
123
0.010
Why?
Syndecan-1
1
2003
72
0.010
Why?
Base Pair Mismatch
1
2003
22
0.010
Why?
Cell Count
1
2003
149
0.010
Why?
Antineoplastic Agents
1
2011
1186
0.010
Why?
DNA Repair
1
2003
193
0.010
Why?
Alcohol Drinking
1
2003
226
0.010
Why?
Molecular Sequence Data
1
2003
793
0.010
Why?
Anti-Bacterial Agents
1
2007
747
0.010
Why?
Smoking
1
2003
512
0.010
Why?
Multiple Myeloma
1
2007
2954
0.010
Why?
Suen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description